HLB Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	156,070	251,873	934,494	331,363	365,136	378,914
Market Cap Growth	-54.78%	-73.05%	182.02%	-9.25%	-3.64%	-51.22%
Enterprise Value	201,829	270,609	946,064	315,400	359,859	380,861
Last Close Price	1686.00	2857.14	10621.32	3977.32	4907.60	5990.56
Forward PE	-	103.69	103.69	103.69	103.69	103.69
PS Ratio	2.31	3.62	17.01	6.30	8.61	8.69
PB Ratio	0.89	1.45	5.14	1.93	2.85	2.91
P/TBV Ratio	3.25	1.82	6.37	2.21	3.28	3.31
P/FCF Ratio	-	-	1435.95	109.54	-	-
P/OCF Ratio	-	-	725.68	99.60	-	-
EV/Sales Ratio	2.99	3.89	17.22	6.00	8.49	8.74
EV/EBITDA Ratio	-	260.12	2022.13	-	-	-
EV/FCF Ratio	-	-	1453.73	104.26	-	-
Debt / Equity Ratio	0.23	0.23	0.13	0.06	0.41	0.39
Debt / EBITDA Ratio	-	38.98	49.91	-	-	-
Debt / FCF Ratio	-	-	35.88	3.31	-	-
Net Debt / Equity Ratio	0.12	-0.03	-0.08	-0.13	-0.09	-0.38
Net Debt / EBITDA Ratio	-11.62	-5.24	-30.82	57.35	2.03	5.27
Net Debt / FCF Ratio	-2.68	0.58	-22.16	-7.38	0.97	4.09
Asset Turnover	0.30	0.31	0.26	0.27	0.23	0.28
Inventory Turnover	9.66	9.44	8.40	7.70	7.66	13.82
Quick Ratio	0.94	2.31	1.46	1.58	1.24	1.91
Current Ratio	1.34	2.84	1.70	1.86	1.37	2.00
Return on Equity (ROE)	-5.41%	-5.44%	-12.97%	-1.98%	-8.97%	-15.42%
Return on Assets (ROA)	-1.44%	-1.00%	-2.27%	-2.85%	-2.49%	-4.45%
Return on Capital Employed (ROCE)	-2.70%	-1.80%	-4.10%	-5.10%	-5.80%	-8.30%
Earnings Yield	-5.82%	-3.66%	-2.44%	-0.69%	-3.11%	-4.54%
FCF Yield	-5.02%	-3.76%	0.07%	0.91%	-3.34%	-3.19%
Buyback Yield / Dilution	-3.55%	-4.35%	-3.23%	-14.46%	-10.86%	-7.26%